lifestyle.californiaconsumerbanking.com

Author: Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates

Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer

April 29, 2026
The Laughing Cow® Introduces Bold and Creamy Dill Pickle Flavor to Cheese Lovers Everywhere

April 29, 2026
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

April 28, 2026
Magnum Brings Dessert to the Desert as Coachella’s First-Ever Frozen Dessert Sponsor

April 28, 2026
TACO BELL’S LIVE MÁS LIVE IS BACK AS A MUST-WATCH SPECTACLE, WHERE 2026 MENU REVEALS COLLIDE WITH HOLLYWOOD STAR POWER – STREAMING FOR THE FIRST TIME EVER ON PEACOCK

April 28, 2026
Butterball Cook from Frozen Premium Whole Turkey Wins Distinguished Product Award

April 28, 2026
FDA Approves VUEWAY® (gadopiclenol) Solution for Injection, Intravenous Use, for Use in Neonates and Infants

April 28, 2026
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

March 30, 2026
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

March 18, 2026
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer

March 11, 2026